Actionable news
All posts from Actionable news
Actionable news in CPHD: CEPHEID,

5 Top Biotech Movers of the Past Week

Over the past week, a few biotech companies made absolutely massive runs. In the past year, the health care sector was on fire from positive trials, U.S. Food and Drug Administration (FDA) approvals and mergers and acquisitions. These companies 24/7 Wall St. has picked stood out from the rest with at least 25% gains over the course of the week. We have included information about each company, as well as recent trading activity and the consensus price target.

Cepheid Inc. (NASDAQ: CPHD) tanked in the middle of week on news that the company cut its guidance for the year when it reported preliminary results. For the third quarter, the company expects total revenue to be approximately $126.5 million, and the net loss per share is expected about $0.32. Over week, shares fell 24.6%, and they are down only 38.8% year to date. Shares of Cepheid traded at $33.67 on Friday’s close. The stock has a consensus analyst price target...